Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir.
López Galera
R M
RM
Ribera Pascuet
E
E
Esteban Mur
J I
JI
Montoro Ronsano
J B
JB
Juárez Giménez
J C
JC
D000069446:Atazanavir Sulfate; D020948:Cat's Claw / Q000009:adverse effects; D005260:Female; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D041743:Herb-Drug Interactions; D006801:Humans; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D028321:Plant Preparations / Q000008:administration & dosage / Q000009:adverse effects; D011725:Pyridines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D019258:Saquinavir / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D028321:Plant Preparations; D011725:Pyridines; D000069446:Atazanavir Sulfate; D019258:Saquinavir; D019438:Ritonavir